76 related articles for article (PubMed ID: 20566339)
1. Diethyl sulfate induced Cdk2-dependent centrosome amplification in CHL cells.
Hu E; Fu J; Zhao P; Yao B; Qi Y; Yuan Z; Zhou Z
Toxicology; 2010 Sep; 275(1-3):58-64. PubMed ID: 20566339
[TBL] [Abstract][Full Text] [Related]
2. NF-κB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer.
Liu JL; Ma HP; Lu XL; Sun SH; Guo X; Li FC
Int J Oncol; 2011 Oct; 39(4):915-24. PubMed ID: 21769424
[TBL] [Abstract][Full Text] [Related]
3. Centrosome-associated NDR kinase regulates centrosome duplication.
Hergovich A; Lamla S; Nigg EA; Hemmings BA
Mol Cell; 2007 Feb; 25(4):625-34. PubMed ID: 17317633
[TBL] [Abstract][Full Text] [Related]
4. Centrosome-targeting region of CG-NAP causes centrosome amplification by recruiting cyclin E-cdk2 complex.
Nishimura T; Takahashi M; Kim HS; Mukai H; Ono Y
Genes Cells; 2005 Jan; 10(1):75-86. PubMed ID: 15670215
[TBL] [Abstract][Full Text] [Related]
5. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
6. Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification.
Hanashiro K; Brancaccio M; Fukasawa K
Oncogene; 2011 May; 30(19):2188-97. PubMed ID: 21242972
[TBL] [Abstract][Full Text] [Related]
7. Chronic exposure to lead chromate causes centrosome abnormalities and aneuploidy in human lung cells.
Holmes AL; Wise SS; Sandwick SJ; Lingle WL; Negron VC; Thompson WD; Wise JP
Cancer Res; 2006 Apr; 66(8):4041-8. PubMed ID: 16618723
[TBL] [Abstract][Full Text] [Related]
8. Cyclin E-dependent localization of MCM5 regulates centrosome duplication.
Ferguson RL; Maller JL
J Cell Sci; 2008 Oct; 121(Pt 19):3224-32. PubMed ID: 18799789
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells.
Leontovich AA; Salisbury JL; Veroux M; Tallarita T; Billadeau D; McCubrey J; Ingle J; Galanis E; D'Assoro AB
Oncol Rep; 2013 May; 29(5):1785-8. PubMed ID: 23446853
[TBL] [Abstract][Full Text] [Related]
10. Centrosome abnormalities and genomic instability induced by human papillomavirus oncoproteins.
Duensing S; Münger K
Prog Cell Cycle Res; 2003; 5():383-91. PubMed ID: 14593733
[TBL] [Abstract][Full Text] [Related]
11. Induction of centrosome amplification and chromosome instability in p53-deficient lung cancer cells exposed to benzo[a]pyrene diol epoxide (B[a]PDE).
Shinmura K; Iwaizumi M; Igarashi H; Nagura K; Yamada H; Suzuki M; Fukasawa K; Sugimura H
J Pathol; 2008 Nov; 216(3):365-74. PubMed ID: 18788085
[TBL] [Abstract][Full Text] [Related]
12. Induction of centrosome amplification during arsenite-induced mitotic arrest in CGL-2 cells.
Yih LH; Tseng YY; Wu YC; Lee TC
Cancer Res; 2006 Feb; 66(4):2098-106. PubMed ID: 16489010
[TBL] [Abstract][Full Text] [Related]
13. Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression.
Koutsami MK; Tsantoulis PK; Kouloukoussa M; Apostolopoulou K; Pateras IS; Spartinou Z; Drougou A; Evangelou K; Kittas C; Bartkova J; Bartek J; Gorgoulis VG
J Pathol; 2006 Aug; 209(4):512-21. PubMed ID: 16739112
[TBL] [Abstract][Full Text] [Related]
14. A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry.
Matsumoto Y; Maller JL
Science; 2004 Oct; 306(5697):885-8. PubMed ID: 15514162
[TBL] [Abstract][Full Text] [Related]
15. Okadaic acid: chromosomal non-disjunction analysis in human lymphocytes and study of aneugenic pathway in CHO-K1 cells.
Hégarat LL; Orsière T; Botta A; Fessard V
Mutat Res; 2005 Oct; 578(1-2):53-63. PubMed ID: 15885711
[TBL] [Abstract][Full Text] [Related]
16. Centrosome aberrations and G1 phase arrest after in vitro and in vivo treatment with the SRC/ABL inhibitor dasatinib.
Fabarius A; Giehl M; Rebacz B; Krämer A; Frank O; Haferlach C; Duesberg P; Hehlmann R; Seifarth W; Hochhaus A
Haematologica; 2008 Aug; 93(8):1145-54. PubMed ID: 18519516
[TBL] [Abstract][Full Text] [Related]
17. Association of G1/S-phase and late S-phase checkpoints with regulation of cyclin-dependent kinases in Chinese hamster ovary cells.
D'Anna JA; Valdez JG; Habbersett RC; Crissman HA
Radiat Res; 1997 Sep; 148(3):260-71. PubMed ID: 9291358
[TBL] [Abstract][Full Text] [Related]
18. Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint.
D'Assoro AB; Busby R; Suino K; Delva E; Almodovar-Mercado GJ; Johnson H; Folk C; Farrugia DJ; Vasile V; Stivala F; Salisbury JL
Oncogene; 2004 May; 23(23):4068-75. PubMed ID: 15064746
[TBL] [Abstract][Full Text] [Related]
19. Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity.
Cheng A; Balczon R; Zuo Z; Koons JS; Walsh AH; Honkanen RE
Cancer Res; 1998 Aug; 58(16):3611-9. PubMed ID: 9721869
[TBL] [Abstract][Full Text] [Related]
20. Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma.
Shinmura K; Tao H; Nagura K; Goto M; Matsuura S; Mochizuki T; Suzuki K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
Lung Cancer; 2011 Jan; 71(1):19-27. PubMed ID: 20434789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
